Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Retained Earnings (2016 - 2025)

Historic Retained Earnings for Haemonetics (HAE) over the last 16 years, with Q4 2025 value amounting to $381.1 million.

  • Haemonetics' Retained Earnings fell 283.99% to $381.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $381.1 million, marking a year-over-year decrease of 283.99%. This contributed to the annual value of $352.2 million for FY2025, which is 229.76% down from last year.
  • According to the latest figures from Q4 2025, Haemonetics' Retained Earnings is $381.1 million, which was down 283.99% from $336.3 million recorded in Q3 2025.
  • In the past 5 years, Haemonetics' Retained Earnings ranged from a high of $392.2 million in Q4 2024 and a low of -$29.5 million during Q2 2021
  • Over the past 5 years, Haemonetics' median Retained Earnings value was $296.5 million (recorded in 2023), while the average stood at $261.6 million.
  • As far as peak fluctuations go, Haemonetics' Retained Earnings skyrocketed by 107544.89% in 2023, and later tumbled by 874.08% in 2025.
  • Quarter analysis of 5 years shows Haemonetics' Retained Earnings stood at $169.4 million in 2021, then soared by 32.09% to $223.8 million in 2022, then soared by 51.98% to $340.1 million in 2023, then grew by 15.33% to $392.2 million in 2024, then dropped by 2.84% to $381.1 million in 2025.
  • Its last three reported values are $381.1 million in Q4 2025, $336.3 million for Q3 2025, and $356.0 million during Q2 2025.